DIRS.INFO The most relevant business & tech news

☆ CNBC Daily Open: Dow posts best week since May, Tesla staff down by 14%
▼ + stars: | 2024-06-24 | by ( Abid Ali | ) www.cnbc.com time to read: +3 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. The tech-centric Nasdaq Composite remained flat, while the Dow Jones Industrial Average had its best week since May, rising 1.45%. The yield on the 10-year Treasury ticked higher and U.S. oil prices rose 2.9% for the week. [PRO] Comeback stocksThe S&P 500 has soared to record levels, fueled by the AI boom, but not all stocks are riding the wave.

Persons: JPMorgan Chase, Goldman Sachs, Tesla, Elon Musk, Musk, Tim Lugo, William Blair's Organizations: CNBC, Nvidia, Microsoft, Apple, Nasdaq, Dow Jones, Citigroup, JPMorgan, Bank of America, Apple Intelligence, Union, Therapeutics, FDA, Organization for Rare Disorders, Nike, Starbucks Locations: U.S

☆ Supreme Court rejects appeals brought by RFK Jr-founded anti-vaccine group over Covid shots
▼ + stars: | 2024-06-24 | by ( Lawrence Hurley | ) www.cnbc.com time to read: +1 min

The Supreme Court on Monday turned away two Covid-related appeals brought by Children's Health Defense, the anti-vaccine group founded by independent presidential candidate Robert F. Kennedy Jr. In the FDA case, the group claimed in court papers that Covid vaccines were "ineffective and lacked proper vetting." Circuit Court of Appeals found that Kennedy's group did not have legal standing to sue. Kennedy is listed as a lawyer on the Rutgers filing at the Supreme Court despite his leave of absence from the group. In a separate vaccine-related case, the court also turned away a challenge to Connecticut's decision to repeal a religious exemption for school vaccinations.

Persons: Robert F, Kennedy Jr, Kennedy Organizations: Children's Health Defense, Food, Rutgers University, FDA, Circuit, Appeals, Rutgers, Democratic, Health Defense Locations: Phoenix , Arizona, New Jersey, Orleans, Philadelphia

☆ Groundbreaking study shows why drinking from plastic bottles may increase your risk of type 2 diabetes
▼ + stars: | 2024-06-24 | by ( ) www.businessinsider.com time to read: +4 min

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read previewScientists have long suspected that industrial chemicals used in plastic water bottles can disrupt human hormones. Now, a groundbreaking new study shows direct evidence that bisphenol A — or, BPA, a chemical used to package food and drink — can reduce sensitivity to insulin, a hormone that helps regulate blood sugar. An impaired ability to respond to insulin, known as insulin resistance, can mean chronically high blood sugar levels and a much higher risk of type 2 diabetes. "We were surprised to see that reducing BPA exposure, such as using stainless steel or glass bottles and BPA-free cans, may lower diabetes risk."

Persons: —, Todd Hagobian, They've, Hagobian Organizations: Service, Business, American Diabetes Association, California Polytechnic State University, EPA, FDA, European Commission Locations: California

☆ Opinion: Destined to be a lame duck
▼ + stars: | 2024-06-23 | by ( Richard Galant | ) edition.cnn.com time to read: +18 min

We’re looking back at the strongest, smartest opinion takes of the week from CNN and other outlets. When Biden and Trump meet in a debate on CNN Thursday, expect part of the audience to be wondering exactly who and what will come next. Biden, who’s battling low approval ratings, is sticking with Vice President Kamala Harris, whose polls are also bleak. There were 28, and we’ve had 11 so far this year, Bridget Johnson noted in the first of a CNN Opinion series about America’s preparedness. “It’s a measure of his hold on American society that he’s still revered a half-century later,” wrote Frederic J. Frommer.

Persons: Franklin D, Roosevelt, “, ”, Alexander Wiley of, Adolph Sabath, Sabath, can’t, Joe Biden, Donald Trump —, Biden, who’s, Kamala Harris, Ronald Reagan’s, George H.W, George H.W . Bush, Trump, Julian Zelizer, Zelizer, it’s, Facebook “ Trump, ’ Trump, Hunter Biden, ” Terry Szuplat, Barack Obama, I’ve, that’s, Obama, Dan, ’, don’t, … Don’t, Melinda French Gates, Douglas Heye, Bob Good, Trump Dean Obeidallah, Clay Jones, we’ve, Bridget Johnson, Johnson, “ we’re, Richard Serino, Irma, Maria, Hurricane Maria, Mark Wolfe, ” Drew Sheneman, Anna Bershteyn, Michael Diamond, Roe, Wade, Karen Finney, Jennifer Tucker, Chuck Schumer's, Chuck Schumer, Schumer, he’s, John Kasich, Bill DeBlasio, Donald Trump, Sarah Palin, Biden’s, Jill Filipovic, Walt Handelsman, Luther Terry, Vivek H, Murthy, ” Kara Alaimo, Dolly Parton, Allison Hope, Dolly Parton “, Parton, ” Hope, Ericka Andersen, ’ Andersen, Andersen, Dolly, Nathan B, Baskind, Weeks, Samantha Baskind, Uncle Nate, Nathan Baskind, David, ” Samantha Baskinshe, ” Don’t, Phil Hands, Nadine Pienede, Frida Ghitis, Adam Plowright, Sara Stewart, Andrew McCarthy, Rohit Chopra, Willie Mays Bill Bramhall, Willie Mays, Frederic J, Frommer, ” Frommer, Mays, —, ” Mays, Vic Wertz, It’s Organizations: CNN, Republicans couldn’t, Democratic, GOP, Alexander Wiley of Wisconsin . Rep, Illinois Democrat, New York Times, Trump, Biden, Twitter, Facebook, UFC, Democrats, Braver, Trump Dean, US, FEMA, Hurricane, Ricans, Ledger, Agency, “, Independence, ”, Times, Federalist, Army, Journal, Tribune, New York Daily, Cleveland Indians, New York Giants Locations: Illinois, George H.W ., New York, American, ” “ Ohio, John Kasich , New York City, Donald Trump , Alaska, Switzerland, France, Normandy, Wisconsin, Juneteenth, Haiti, Putin’s, Korea, “

☆ The 5 biggest cases the Supreme Court hasn't yet decided
▼ + stars: | 2024-06-23 | by ( Brent D. Griffiths | ) www.businessinsider.com time to read: +8 min

The nation's highest court typically wraps up its business by the end of June, but court watchers count roughly a dozen major pending decisions. Trump v. United States: The Trump immunity caseThe implications for Trump alone made this the most closely-watched case this term. As Justice Neil Gorsuch said during oral arguments, the court may write "a rule for the ages." Justices heard oral arguments in a case brought by commercial fishermen about a rule requiring them to pay for monitors that track potential overfishing. Justice Elena Kagan said during oral arguments that 70 Supreme Court rulings and more than 17,000 lower-court decisions have relied on Chevron.

Persons: —, Donald Trump's, Trump, Neil Gorsuch, Ketanji Brown Jackson, Jack Smith's, Smith, Lev Radin, Fischer, Joseph Fischer's, John Roberts, Loper, Raimondo, Biden, Elena Kagan, Andrew Harnik, Moyle, Roe, Joshua Turner, Ken Paxton, Brandon Bell, Ron DeSantis Organizations: Service, Trump, Business, . United, Police, United, Enron, Capitol, Electoral, Biden, Washington Post, Loper Bright Enterprises, FDA, Chevron, Natural Resources Defense, Inc, Getty, Idaho, Labor, Paxton, Industry, Gov, The Washington Post, Court, GOP Locations: . United States, United States, Pennsylvania, Chevron U.S.A, Idaho's, Idaho, Texas, Red, Florida

☆ Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
▼ + stars: | 2024-06-21 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

Eli Lilly presented the new data from the trials at the American Diabetes Association's 84th Scientific Sessions in Orlando, Florida, on Friday. An estimated 80 million patients in the U.S. experience the disease, Eli Lilly said in a press release. Disease resolution for OSA is defined as a patient having fewer than five AHI events per hour, according to Eli Lilly. Eli Lilly on Friday reiterated that Zepbound met the main goal of the trial, which was reducing AHI events. Eli Lilly previously announced that the FDA granted Zepbound "fast track designation" for patients with moderate-to-severe OSA and obesity.

Persons: Eli Lilly, Zepbound, Patrik Jonsson, Jonsson, Leonard Glass, —, Eli Lilly's Organizations: Food and Drug Administration, Diabetes, CNBC, OSA, FDA Locations: Orlando , Florida, U.S

☆ TD Cowen's Ritu Bara talks Sarepta stock skyrocketing on FDA gene therapy approval
▼ + stars: | 2024-06-21 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTD Cowen's Ritu Bara talks Sarepta stock skyrocketing on FDA gene therapy approvalRitu Baral, TD Cowen Sr. Biotechnology Analyst, joins 'Closing Bell Overtime' to talk Sarepta's approval from the FDA for its Duchenne gene therapy and how it drove the stock to its best trading day in a year.

Persons: Ritu Bara, Baral, TD Cowen Organizations: FDA, Biotechnology

☆ Sarepta CEO on what's next after expanded muscular dystrophy drug approval
▼ + stars: | 2024-06-21 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSarepta CEO on what's next after expanded muscular dystrophy drug approvalDouglas Ingram, Sarepta CEO, joins 'Fast Money' to talk FDA approval of Elevidys and its impact on the company's stock.

Persons: what's, Douglas Ingram

☆ Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
▼ + stars: | 2024-06-21 | by ( Sean Conlon | ) www.cnbc.com time to read: +2 min

Hertz Global — Shares rose more than 10% after the car rental giant upsized a bond offering to $1 billion . Asana — The stock popped 10.5% after the software firm announced a share buyback plan that would cost $150 million. Nvidia — The chipmaker dropped another 1% following a 3.5% decline in the previous session. Gilead Sciences — Shares of the pharmaceutical company popped around 2%, adding to an 8.5% rally from the previous session. Palo Alto Networks — Shares rose 2.4% after D.A.

Persons: Gilead, LendingTree, Davidson, D.A, Boyd Gaming, Boyd, —, Alex Harring, Yun Li, Lisa Kailai Han, Hakyung Kim, Michelle Fox Organizations: Therapeutics, U.S . Food, Drug Administration, FDA, Hertz, Nvidia, Gilead Sciences, Bloomberg, Palo Alto, D.A, Penn Entertainment, Boyd, Reuters, Boeing Locations: U.S, Gilead, Palo, cybersecurity, Thursday's

☆ FDA OKs first menthol e-cigarettes, citing potential to help adult smokers
▼ + stars: | 2024-06-21 | by ( ) www.cnbc.com time to read: +3 min

The Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that vaping flavors can reduce the harms of traditional tobacco smoking. The FDA said it authorized four menthol e-cigarettes from Njoy, the vaping brand recently acquired by tobacco giant Altria , which also sells Marlboro cigarettes. "This decision could mean we'll never be able to close the Pandora's box of the youth vaping epidemic," said Meredith Berkman, co-founder of Parents Against Vaping E-cigarettes. Njoy is one of only three companies that previously received FDA's OK for vaping products. Altria's data showed Njoy e-cigarettes helped smokers reduce their exposure to the harmful chemicals in traditional cigarettes, the FDA said.

Persons: Meredith Berkman, Vaping, —, vaping, Vuse, Matthew Farrelly Organizations: Drug Administration, FDA, Marlboro, Parents, Nielsen, Reynolds American, FDA's Center for Tobacco Products Locations: U.S

☆ Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
▼ + stars: | 2024-06-20 | by ( Angelica Peebles | In Angelicapeebles | ) www.cnbc.com time to read: +3 min

Gilead 's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. The results bring Gilead one step closer to introducing a new form of pre-exposure prophylaxis, or PrEP, and broadening its HIV business. If those results are positive, the company could bring lenacapavir for PrEP to market as soon as late 2025. RBC Capital Markets analyst Brian Abrahams expects Gilead's shot will significantly increase the number of people interested in preventive HIV medicine. In its statement disclosing the lenacapavir trial results Thursday, Gilead said it plans to share an update on how it plans to address access in such countries where people suffer high incidence rates of HIV.

Persons: Gilead, Jared Baeten, Gilead's Truvada, Bruce Richman, Tim Oliver, they'd, Brian Abrahams, Gilead's, — CNBC's Leanne Miller Organizations: Food and Drug Administration, PrEP, Centers for Disease Control, Prevention, Health, FDA, RBC Capital Locations: U.S, New York

☆ Children with high BMIs should not use obesity medications like WeGovy, US doctors warn
▼ + stars: | 2024-06-19 | by ( Julia Naftulin | ) www.businessinsider.com time to read: +4 min

Read previewWith weight-loss drugs like WeGovy and Ozempic dominating many of today's consumer healthcare conversations, there's a mounting concern for a particularly vulnerable group: children. In January 2023, the American Academy of Pediatrics (AAP) recommended that healthcare providers offer weight-loss medications, in addition to lifestyle adjustments, to treat obesity in children 12 and older. And in addition, there was limited evidence on weight loss maintenance after medications were discontinued in children," Nicholson said. These injectable drugs have proven successful as weight-loss interventions for adults with obesity, early research shows. Nicholson said clinicians have used lifestyle interventions, like nutrition and exercise plans, to help children with obesity lose weight and reduce risk factors like hypertension, diabetes, and liver disease.

Persons: —, Eli Lilly, Hilary Brueck, Wanda Nicholson, Nicholson, Amanda Staiano, Staino Organizations: Service, Pharmaceutical, Novo Nordisk, Business, American Academy of Pediatrics, US Preventive Services, Force, George Washington University School of Public Health, FDA, Pennington Biomedical Research, of Louisiana State University Locations: Pennington

☆ Dollar Tree left children's apple sauces on shelves for months after a recall for lead contamination, FDA says in letter threatening possible legal action
▼ + stars: | 2024-06-19 | by ( Madeline Stone | ) www.businessinsider.com time to read: +1 min

Dollar Tree failed to remove lead-contaminated apple sauce from some of its stores, the FDA said. Products linked to child illnesses were said to still be on shelves months after they were recalled. The FDA said it could take further legal action if its concerns were not addressed. The FDA warned it could take further legal action if Dollar Tree did not properly address the violations. Several products — including WanaBana apple cinnamon fruit puree pouches, Schnucks cinnamon-flavored apple sauce pouches, and Weis cinnamon apple sauce pouches — were recalled in October after consumption was linked to elevated levels of lead.

Persons: — Organizations: FDA, Service, US Food and Drug Administration, Business

☆ Dr. Scott Gottlieb on protecting teens on social media: Ultimately parents need to get engaged
▼ + stars: | 2024-06-18 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb on protecting teens on social media: Ultimately parents need to get engagedFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the need for action against the dangers that social media poses to children, the likelihood of Congress mandating warning labels on social media apps similar to cigarettes and alcohol, what action parents can take, and more.

Persons: Scott Gottlieb

☆ To help children with high BMI, expert panel recommends 26 hours of behavior coaching — but not weight-loss drugs
▼ + stars: | 2024-06-18 | by ( Jen Christensen | ) edition.cnn.com time to read: +9 min

The task force suggested that extensive and intensive behavioral interventions are the best way to help a child get to a healthy weight. A high BMI for a child is defined a little differently than it is for adults, although both use height and weight to estimate mass. Nearly 20% of children in the US have what’s considered a high BMI. The task force gives its guidelines letter grades based on the most up-to-date science. Under the Affordable Care Act, private insurers must cover preventive services that get a grade of A or B; the new child obesity recommendations got a B grade.

Persons: Susma Vaidya, ”, “, Dr, Mona Sharifi, ” Sharifi, Thomas Robinson, Sarah Armstrong, haven’t, Sharifi, Justin Ryder, Stanley Manne, Robert H, Lurie, “ I’ve, ” Ryder, Wegovy, Alli, Lomaira, John Ruiz, Sanjay Gupta, “ There’s, ” Vaidya, Vaidya, pharmacotherapy Organizations: CNN, US Preventive Services, Force, American Academy of Pediatrics, BMI, US Centers for Disease Control, Affordable, National Hospital, Yale School of Medicine, Stanford Solutions Science Lab, Department of Pediatrics, Pediatrics, Adolescent Health, Duke University Medical School, Stanley Manne Children’s, Ann, Lurie Children’s Hospital of Chicago, University of Arizona, CNN Health, FDA Locations: Washington

☆ FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
▼ + stars: | 2024-06-17 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

The Food and Drug Administration on Monday approved Merck 's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said. It's the first pneumococcal conjugate vaccine designed specifically for adults and aims to provide broader protection than the available shots on the market, according to the drugmaker. Healthy adults can suffer from pneumococcal disease. Around 150,000 U.S. adults are hospitalized with pneumococcal pneumonia each year, Platt said. Death from the more serious form of the disease is highest among adults 50 and above, Merck said in a release in December.

Persons: Merck, Merck's, Heather Platt, Platt Organizations: Drug Administration, CNBC, Centers for Disease Control

☆ His wife had a common skin condition and tried expensive creams for over 20 years. She became 'patient zero' for his personalized skincare company — and had clear skin in a month.
▼ + stars: | 2024-06-17 | by ( Julia Pugachevsky | ) www.businessinsider.com time to read: +10 min

For 20 years after getting pregnant, Cherry Jia tried everything to fade the dark patches on her face. After giving birth to her son, she had melasma, a fairly common skin discoloration caused by hormonal fluctuations during pregnancy. The treatments they sold for dark spots had no effect on her skin. Jia said Musely's top-selling products treat aging concerns like dark spots, rosacea, and hair thinning. MuselyPart of the boom comes from the desire for products that target specific skin concerns, like dark spots or wrinkles.

Persons: Musely, —, Cherry Jia, she'd, Jack Jia, Cherry, Jack Jia Jia, Marie Jhin, he'd, Jhin, Lori Bush, Kimber Maderazzo, dermatologists, Jia, Jhin . Cherry Jia's, Jack Jia's, Musely Jia, estriol, they've, isn't, it's Organizations: Healthcare, Service, Musely, Jhin, FDA, New York Times Locations: drugstores

☆ Supreme Court’s abortion pill ruling puts new focus on conservative Trump judge in Texas
▼ + stars: | 2024-06-15 | by ( John Fritze | Tierney Sneed | ) edition.cnn.com time to read: +9 min

In the mifepristone case, Kacsmaryk’s initial ruling was notable not just for its sweeping nature but in how he embraced the anti-abortion movement’s sensational rhetoric about the procedure. The groups fighting mifepristone argue that the Supreme Court’s decision shouldn’t affect the states’ ability to sue. Both the FDA and several medical groups, including the American Medical Association, told the Supreme Court that mifepristone is safe. But the Supreme Court knocked that argument aside, noting that federal law already allows doctors to avoid performing procedures that violate their conscience. Adam Unikowsky, a veteran Supreme Court litigator who has closely followed the mifepristone case, predicted it will be hard for the states to get the issue back before the Supreme Court.

Persons: Matthew Kacsmaryk, Donald Trump, ”, Carrie Flaxman, Brett Kavanaugh, mifepristone, ” Kavanaugh, Roe, Wade, Kansas –, Andrew Bailey, Kacsmaryk, Joe Biden’s, Biden, it’s, ” Julia Kaye, Erin Hawley, “, –, Adam Unikowsky, litigator, Unikowsky, They’re, ” Jaime Santos, Goodwin, “ that’s, Kavanaugh, isn’t Organizations: CNN, Trump, mifepristone, Supreme, Food, Democracy Forward, and Drug Administration, Republican, Alliance for Hippocratic, Biden, ACLU, Defending, FDA, American Medical Association Locations: Texas, Amarillo, – Missouri, Idaho, Kansas, Missouri, Texas ’, Mexico, Missouri , Idaho

☆ Brain science start-up Neuroelectrics uses electricity and a headcap to reduce seizures in patients with epilepsy. Now it needs FDA approval
▼ + stars: | 2024-06-14 | by ( Cristy Garratt Maria Gomez De Sicart | Cristy Garratt | Https | ) www.cnbc.com time to read: +1 min

High up in the hills of Barcelona, brain science start-up Neuroelectrics is developing therapies that it says will improve the lives of people living with brain disease. Its main product is a headcap, which monitors the brain's electrical activity and stimulates regions of the brain with mild electrical currents. Co-founder and CEO Ana Maiques believes it will significantly improve the lives of people suffering with epilepsy. In addition to epilepsy, Maiques and her team are optimistic that the headgear can also be used to treat depression and Alzheimer's. So, when you have epilepsy, you have an electrical discharge in one area of your brain, so they can really target and help them," said Roser Sanchez-Todo, R&D director for Neuroelectrics' brain modelling department.

Persons: Ana Maiques, Maiques, Roser Sanchez, Neuroelectrics Organizations: CNBC Tech, U.S . Food, Drug Administration Locations: Barcelona

☆ Abortion: Trump walks fine line but allies and activists have big plans for a second term
▼ + stars: | 2024-06-14 | by ( Phil Mattingly | Andrew Seger | ) edition.cnn.com time to read: +16 min

“I believe he’ll be a pro-life president in the future also.”Many senior Trump administration alumni and allies are now mapping out and drafting policy options for a second Trump term. A second Trump term would also put back in place and expand restrictions on Title X grants – federal funds for public and nonprofit groups that provide family planning. Resurrecting these actions in a second Trump would almost entirely be up to the discretion of whomever he appoints to lead the relevant federal agencies. With Roe v. Wade’s protections erased, anti-abortion activists would like a second Trump administration to push harder than it did before – especially in restricting access to mifepristone. Abortion rights advocates worry he could play an outsize role shaping abortion restrictions in a potential second Trump administration.

Persons: Donald Trump’s, Ronald Reagan, ”, Roe, Wade, Dobbs, Trump, ” Trump, “, Trump –, Joe Biden’s, Kellyanne Conway, ’ ”, Mary Ziegler, Davis, Roger Severino, Trump’s, Reagan, Biden, ” Julie Lewis, Ziegler, David S, Cohen, Comstock, Skye Perryman, ” Mark Lee Dickson, Donald J, ” Dickson, “ He’s, Jonathan Mitchell, Mitchell Organizations: CNN, Trump, New, Capitol, “ Republicans, Democratic, Republican, Fox, Heritage Foundation, Biden’s, Department, University of California, Trump Health, Human Services, HHS, Food and Drug Administration, DOJ, UC Davis, Food, FDA, ” Drexel University, White, Justice Department, Democracy, Department of Justice, Cities, mifepristone, Time Locations: New York, Florida, Arizona, Mexico, Texas, America, United States, Colorado

The Supreme Court justices suggested that abortion opponents had other ways to seek stricter rules for abortion drugs in the court’s unanimous ruling that rejected a group of anti-abortion organizations and doctors challenging the Food and Drug Administration’s current regulations for a widely used pill. Much of Kavanaugh’s opinion covered the various legal thresholds a plaintiff must reach to make it appropriate for courts to intervene in a dispute. He noted that federal law already protects individual health care providers who have objections to performing abortions for moral reasons. “In short, given the broad and comprehensive conscience protections guaranteed by federal law, the plaintiffs have not shown—and cannot show—that FDA’s actions will cause them to suffer any conscience injury,” Kavanaugh wrote. Justice Clarence Thomas wrote a concurrence to bring up other issues he had with the anti-abortion groups’ standing claims.

Persons: Brett Kavanaugh, ”, Kavanaugh, ” Kavanaugh, Clarence Thomas Organizations: Food, Legislative

☆ Read the Court’s Decision to Uphold Access to Abortion Pill
▼ + stars: | 2024-06-13 | by ( ) www.nytimes.com time to read: +3 min

Held: Plaintiffs lack Article III standing to challenge FDA's actions regarding the regulation of mifepristone. (a) Article III standing is a “bedrock constitutional requirement that this Court has applied to all manner of important disputes." Causation requires the plaintiff to establish that the plaintiff's injury likely was caused or likely will be caused by the defendant's conduct. Because plaintiffs do not prescribe or use mifepristone, plaintiffs are unregulated parties who seek to challenge FDA's regulation of others. Plaintiffs advance several complicated causation theories to connect FDA's actions to the plaintiffs' alleged injuries in fact.

Persons: “, Allen, Wright, Ramirez, Summers, Lujan Organizations: Fifth Circuit, FDA, Earth Island Institute, of Wildlife Locations: States, . Texas

☆ Supreme Court rejects challenge to abortion pill mifepristone
▼ + stars: | 2024-06-13 | by ( John Fritze | Tierney Sneed | ) edition.cnn.com time to read: +8 min

As those bans helped propel the demand for medication abortion, mifepristone became a logical target for the anti-abortion movement. None of those lower court rulings went into effect because the Supreme Court intervened last year and ordered that the status quo around mifepristone remain in place until the justices reviewed the case. The Supreme Court heard arguments in March. Both the FDA and several medical groups, including the American Medical Association, told the Supreme Court that mifepristone is safe. The mifepristone appeal was one of two abortion cases the high court was considering this month.

Persons: Roe, Wade, Brett Kavanaugh, “, ” Kavanaugh, Kavanaugh, ”, Clarence Thomas, mifepristone, Donald Trump, Matthew Kacsmaryk, —, –, Kacsmaryk, Biden, Steve Vladeck, Joe Biden Organizations: CNN, Food, Legislative, Trump, FDA, US, American Medical Association, Alliance for Hippocratic, University of Texas School of Law, Jackson, Health Organization, Biden Locations: Texas, mifepristone, Amarillo , Texas, Dobbs v, Idaho

☆ Stocks making the biggest moves premarket: Eli Lilly, General Motors, Shopify
▼ + stars: | 2024-06-11 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Eli Lilly — Eli Lilly shares rose 2% after a panel of FDA advisors recommended the approval of its Alzheimer's drug known as donanemab. General Motors — The automaker's stock added more than 1% after its board authorized a $6 billion stock buyback program . Shopify — The e-commerce stock rose about 1% after JPMorgan initiated coverage with an overweight rating. Apple — Apple shares slipped less than 1% a day after the iPhone maker's Worldwide Developers Conference, where it revealed its artificial intelligence plans , called Apple Intelligence. GameStop — GameStop shares slipped 1% before the bell, continuing its volatile ride.

Persons: Eli Lilly, General Motors, Siri, Keith Gill's, Lee Cole, —, Jesse Pound, Sarah Min Organizations: General, JPMorgan, Apple, Apple Intelligence, Technology, Reuters, Apollo, Kyndryl Holdings, GameStop, Calavo, —, Calavo Growers

☆ Jim Cramer looks at Eli Lilly's outlook as the company's Alzheimer drug goes through FDA
▼ + stars: | 2024-06-11 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJim Cramer looks at Eli Lilly's outlook as the company's Alzheimer drug goes through FDA'Mad Money' host Jim Cramer breaks down Eli Lilly's success in pharmaceutical drugs and where the stock can go from here.

Persons: Jim Cramer, Eli Lilly's Organizations: FDA

Search resuls for: "FDA"

25 mentions found